Literature DB >> 34370118

Vitamin D Receptor Gene Polymorphisms and Risk of Knee Osteoarthritis: Possible Correlations with TNF-α, Macrophage Migration Inhibitory Factor, and 25-Hydroxycholecalciferol Status.

Mohammed H Hassan1, Amer Alkot Mostafa Elsadek2, Marwa Ahmed Mahmoud3, Bakheet E M Elsadek4.   

Abstract

Osteoarthritis (OA) etiology and pathogenesis not yet fully understood. We studied the role of vitamin D receptor single-nucleotide polymorphisms (VDR-SNPs), vitamin D3, serum and synovial macrophage migration inhibitory factor (MIF), and tumor necrosis factor-α (TNF-α) in the development and progression of knee OA (KOA). This study included 205 Egyptian subjects (105 patients with KOA and 100 unrelated, healthy matched subjects selected as controls). The patient group was divided into three groups according to KOA severity (mild, moderate, and severe), with 35 patients in each group. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was used for the ApaI and TaqI SNPs. Vitamin D, serum and synovial TNF-α, and MIF assays were performed using ELISA kits. There were significantly lower serum levels of 25-hydroxycholecalciferol with significant increasing TNF-α and MIF levels in relation to disease severity among the cases (all: p˂0.05).Wild homozygous and heterozygous mutant genotypes (GG+GT) and G allele of ApaI demonstrated risk for KOA development, with odds ratio OR = 6.313 (95% confidence interval (CI) 2.074-19.210) and OR = 1.532 (95%CI 1.013-2.317), respectively. Homozygous mutant CC genotype and C allele of TaqI could be considered a risk factor associated with KOA development, with OR = 2.667 (95%CI 1.270-5.601) and OR = 0.737 (95%CI 0.496-1.095), respectively. VDR-SNPs, vitamin D3, TNF-α, and MIF could play an essential role in the pathogenesis and progression of KOA with mechanistic associations.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  25-Hydroxycholecalciferol; Knee osteoarthritis; Macrophage migration inhibitory factor; PCR–RFLP; Tumor necrosis factor-α; Vitamin D receptor single-nucleotide polymorphisms

Mesh:

Substances:

Year:  2021        PMID: 34370118     DOI: 10.1007/s10528-021-10116-0

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  32 in total

1.  Osteoarthritis: Is OA a mechanical or systemic disease?

Authors:  Flavia M Cicuttini; Anita E Wluka
Journal:  Nat Rev Rheumatol       Date:  2014-07-15       Impact factor: 20.543

2.  The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study.

Authors:  Marita Cross; Emma Smith; Damian Hoy; Sandra Nolte; Ilana Ackerman; Marlene Fransen; Lisa Bridgett; Sean Williams; Francis Guillemin; Catherine L Hill; Laura L Laslett; Graeme Jones; Flavia Cicuttini; Richard Osborne; Theo Vos; Rachelle Buchbinder; Anthony Woolf; Lyn March
Journal:  Ann Rheum Dis       Date:  2014-02-19       Impact factor: 19.103

3.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

4.  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.

Authors:  N Bellamy; W W Buchanan; C H Goldsmith; J Campbell; L W Stitt
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

5.  Synovial tissue inflammation in early and late osteoarthritis.

Authors:  M J Benito; D J Veale; O FitzGerald; W B van den Berg; B Bresnihan
Journal:  Ann Rheum Dis       Date:  2005-02-24       Impact factor: 19.103

6.  Analysis of 25-hydroxy cholecalciferol, immunoglobulin E, and vitamin D receptor single nucleotide polymorphisms (Apa1, Taq1, and Bsm1), among sample of Egyptian children with bronchial asthma: A case-control study.

Authors:  Ahmed El-Abd Ahmed; Mohammed H Hassan; Rana Toghan; Nagwan I Rashwan
Journal:  Pediatr Pulmonol       Date:  2020-04-20

7.  Vitamin D regulation of metalloproteinase activity in matrix vesicles.

Authors:  D D Dean; Z Schwartz; J Schmitz; O E Muniz; Y Lu; F Calderon; D S Howell; B D Boyan
Journal:  Connect Tissue Res       Date:  1996       Impact factor: 3.417

8.  1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases.

Authors:  B D Boyan; Z Schwartz
Journal:  Cells Tissues Organs       Date:  2008-09-01       Impact factor: 2.481

9.  Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis.

Authors:  Nikolaus B Binder; Birgit Niederreiter; Oskar Hoffmann; Richard Stange; Thomas Pap; Thomas M Stulnig; Matthias Mack; Reinhold G Erben; Josef S Smolen; Kurt Redlich
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440

10.  Association between serum Vitamin D deficiency and Knee Osteoarthritis.

Authors:  Hasan Anari; Afsaneh Enteshari-Moghaddam; Yeghaneh Abdolzadeh
Journal:  Mediterr J Rheumatol       Date:  2020-03-31
View more
  1 in total

Review 1.  Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework.

Authors:  Laure-Alix Clerbaux; Maria Cristina Albertini; Núria Amigó; Anna Beronius; Gillina F G Bezemer; Sandra Coecke; Evangelos P Daskalopoulos; Giusy Del Giudice; Dario Greco; Lucia Grenga; Alberto Mantovani; Amalia Muñoz; Elma Omeragic; Nikolaos Parissis; Mauro Petrillo; Laura A Saarimäki; Helena Soares; Kristie Sullivan; Brigitte Landesmann
Journal:  J Clin Med       Date:  2022-07-31       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.